Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low-prevalence population
about
Prevalence of Chlamydia trachomatis in women attending a family planning clinic in Papua New Guinea.Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standardComparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.Low prevalence of Chlamydia trachomatis infection in non-urban pregnant women in Vellore, S. India.Current methods of laboratory diagnosis of Chlamydia trachomatis infections.Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings.Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimensSensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid.Use of gen-probe probe competition assay as a supplement to probes for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital specimensThe Potential Misuse of DNA Probe for the Detection of Neisseria gonorrhoeae and Chlamydía trachomatis When Used for Test of Cure.Efficacy and Tolerance of Single-dose Azithromycin for Treatment of Chlamydial Cervicitis During Pregnancy.Screening for Chlamydia trachomatis infection among infertile women in Saudi ArabiaImproved performance of PACE 2 with modified collection system in combination with probe competition assay for detection of Chlamydia trachomatis in urethral specimens from males.
P2860
Q33935797-B2D49203-95CC-4D8E-BD95-B995FC5C2FA5Q33959268-DF12D309-DD3A-4992-9B8A-D7B6D70E1F74Q33961442-D3331443-0CCA-4011-9400-24FBDB057EF6Q34261506-DDD7F1C6-3FC2-4F5F-AF64-D64ACAFD401BQ35376678-AF80089C-E531-40B0-AC0B-718ED42812B8Q36314501-DB092F95-0AF0-4DC1-A848-17B2319CD538Q36525292-B91F10AD-2D53-4AF2-AC46-9AA05262A0B3Q36526448-08B5A881-F321-4849-8268-FE21E01A9C81Q36527457-EDFA6EE8-2F1E-43BE-B8CC-501779A4C3FDQ36625504-BEEB1CDC-F859-4BB3-903C-91E9177C77DBQ36629123-A56FC37D-04EA-48F0-8C59-614F3789BB08Q36929255-AF1CC2CB-C48C-4A4D-B263-F4B6168543D2Q37072488-772F9691-4A0C-4CAD-A0F7-3342EAF304EA
P2860
Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low-prevalence population
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1993
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of the Clearview Ch ...... in a low-prevalence population
@en
Comparison of the Clearview Ch ...... n a low-prevalence population.
@nl
type
label
Comparison of the Clearview Ch ...... in a low-prevalence population
@en
Comparison of the Clearview Ch ...... n a low-prevalence population.
@nl
prefLabel
Comparison of the Clearview Ch ...... in a low-prevalence population
@en
Comparison of the Clearview Ch ...... n a low-prevalence population.
@nl
P2093
P2860
P1476
Comparison of the Clearview Ch ...... in a low-prevalence population
@en
P2093
Blanding J
Peterson EM
Stranton N
de la Maza L
P2860
P304
P407
P577
1993-06-01T00:00:00Z